Changes in the cannabinoid (CB1) receptor expression level and G-protein activation in kainic acid induced seizures

Epilepsy Research

Volumn 99, Issue 1-2, 2012, Pages 64-68

  Bojnik, Engin ^a   Turunç, Ezgi ^b   Armaĝan, Güliz ^b   Kanit, Lütfiye ^b   Benyhe, Sándor ^a   Yalçin, Ayfer ^b   Borsodi, Anna ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b EGE UNIVERSITY   (Turkey)

Author keywords

ACEA; Cannabinoid receptor; Epilepsy; G protein activation; Kainic acid

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID RECEPTOR INTERACTING PROTEIN 1; CARRIER PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; KAINIC ACID; N (2 CHLOROETHYL) 5,8,11,14 EICOSATETRAENAMIDE; UNCLASSIFIED DRUG;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CB1 GENE; CONTROLLED STUDY; CRIP1 GENE; GADPH GENE; GENE; GENE EXPRESSION; HIPPOCAMPUS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEIZURE; SIGNAL TRANSDUCTION;

ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; CARRIER PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; KAINIC ACID; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; SEIZURES;

EID: 84857912343     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.10.020     Document Type: Article

References (19)

1. Adams I.B., Martin B.R. Cannabis: pharmacology and toxicology in animals and humans. Addiction 1996, 91:1585-1614.
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal. Biochem. 1986, 72:254-284.
3. Chomczynski P.A. Reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993, 15:532-537.
4. Deshpande L.S., Sombati S., Blair R.E., Carter D.S., Martin B.R., DeLorenzo R.J. Cannabinoid CB1 receptor antagonists cause status epilepticus like activity in the hippocampal neuronal culture model of acquired epilepsy. Neurosci. Lett. 2007, 411:11-16.
5. Di Marzo V. Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight. Nat. Neurosci. 2011, 14:9-19.
6. Edwards D.A., Kim J., Alger B.E. Multiple mechanisms of endocannabinoid response initiation in hippocampus. J. Neurophysiol. 2006, 95:67-75.
7. Falenski K.W., Blair R.E., Sim-Selley L.J., Martin B.R., DeLorenzo R.J. Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy. Neuroscience 2007, 146:1232-1244.
8. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 1991, 11:563-583.
9. Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S.C., Cascio M.G., Gutierrez S.O., van der Stelt M., López-Rodriguez M.L., Casanova E., Schütz G., Zieglgänsberger W., Di Marzo V., Behl C., Lutz B. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 2003, 302:84-88.
10. Ng S.K.C., Brust J.C.M., Hauser W.A., Susser M. Illicit drug use and the risk of new onset seizures. Am. J. Epidemiol. 1990, 132:47-57.
11. Niehaus J.L., Liu Y., Wallis K.T., Egertova M., Bhartur S.G., Mukhopadhyay S., Shi S., He H., Selley D.E., Howlett A.C., Elphick M.R., Lewis D.L. CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a. Mol. Pharmacol. 2007, 72:1557-1566.
12. Panikashvili D., Simeonidous C., Ben-Shabat S., Hanus L., Breuer A., Mechoulam R., Shohami E. Nature 2001, 413:527-531.
13. Sokal D.M., Large C.H. The effects of GABA(B) receptor activation on spontaneous and evoked activity in the dentate gyrus of kainic acid treated rats. Neuropharmacology 2001, 40:193-202.
14. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 1994, 42:1-32.
15. Van der Stelt M., Di Marzo V. Cannabinoid receptors and their role in neuroprotection. Neuromol. Med. 2005, 7:37-50.
16. Van der Stelt M., Veldhuis W.B., Maccarrone M., Bär P.R., Nicolay K., Veldink G.A., Di Marzo V., Vliegenthart J.F. Acute neuronal injury, excitotoxicity, and the endocannabinoid system,. Mol. Neurobiol. 2002, 26:317-346.
17. Wallace M.J., Blair R.E., Falenski K.W., Martin B.R., DeLorenzo R.J. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal Lobe epilepsy. J. Pharmacol. Exp. Ther. 2003, 307:129-133.
18. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses. Nature 2001, 410:588-592.
19. Yalcin A. The relative quantification of thioredoxin mRNA expression in the rat hippocampus by real-time PCR following oxidative stress. Acta Biochim. Pol. 2004, 51:1059-1065.